Ranbaxy signs licence deal with S. Korean firm Forbes Ranbaxy will launch Medy-Tox's anti-ageing medicine Neuronox in India to boost its presence in the dermatological segment, said a company statement. |
Wednesday, September 16, 2009
Ranbaxy signs licence deal with S. Korean firm - Forbes
Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment